Matrix Metalloproteinase-9 Is Required for Tumor Vasculogenesis but Not for Angiogenesis: Role of Bone Marrow-Derived Myelomonocytic Cells
Top Cited Papers
Open Access
- 1 March 2008
- journal article
- research article
- Published by Elsevier in Cancer Cell
- Vol. 13 (3), 193-205
- https://doi.org/10.1016/j.ccr.2007.11.032
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- The SDF-1–CXCR4 signaling pathway: a molecular hub modulating neo-angiogenesisTrends in Immunology, 2007
- Regulation of HIF-1α Stability through S-NitrosylationMolecular Cell, 2007
- Monocyte/Macrophage Suppression in CD11b Diphtheria Toxin Receptor Transgenic Mice Differentially Affects Atherogenesis and Established PlaquesCirculation Research, 2007
- Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in miceInternational Journal of Radiation Oncology*Biology*Physics, 2007
- Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasisNature Cell Biology, 2006
- Myeloid lineage progenitors give rise to vascular endotheliumProceedings of the National Academy of Sciences, 2006
- Clodronate-liposome-mediated depletion of tumour-associated macrophages: a new and highly effective antiangiogenic therapy approachBritish Journal of Cancer, 2006
- Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasionMolecular Cancer Therapeutics, 2005
- Tumour-educated macrophages promote tumour progression and metastasisNature Reviews Cancer, 2004
- The biology of VEGF and its receptorsNature Medicine, 2003